about
Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs.Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts)Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy.Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction.Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.Early identification of anthracycline cardiomyopathy: possibilities and implications.Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variablesDihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study Group.Exercise capacity in apparently healthy survivors of cancer.Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancerModeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesCardiomyopathy associated with cancer therapy.Doxorubicin (adriamycin) cardiomyopathy.RGS Proteins in Heart: Brakes on the Vagus.Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.Abbreviated chemotherapy for limited-stage diffuse large B-cell lymphoma after complete resection.Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity.Arginylglycylaspartic Acid-Surface-Functionalized Doxorubicin-Loaded Lipid-Core Nanocapsules as a Strategy to Target Alpha(V) Beta(3) Integrin Expressed on Tumor Cells.Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosisRecent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
P2860
Q30427656-89465A1A-B52F-48EE-951F-6EA25110FD15Q33974943-DDBEE73D-D38E-4666-B060-140C17A28EABQ33985488-32F5DCF0-4B66-41F7-A855-0483C661F551Q34092826-40A0FC65-36E6-4E28-B0AE-BBD2D4B38D95Q34535269-AA50011D-BF3F-4867-B56F-2D26143B408EQ34800157-2C110800-3458-4CDF-9165-940542C46620Q35371321-4DC44EDF-3762-47C1-A80E-7DF72E794669Q35550223-FA79C0C4-A736-4632-A307-B352D4878C6EQ35993715-6DC85AF9-D830-4B09-9D10-32E67D093A5DQ36153755-41F6D12C-23E0-4B55-B964-BDB29A6B4A4CQ36410651-E8303C0B-7E38-4978-A7C4-E392769E22F3Q36864827-D234A44D-8F99-4044-81C0-08A14F342345Q38242641-65E42934-1B70-42BA-8D69-66C42CA99A94Q40162046-4057C2A1-723B-45B3-9C09-D5D213BF1508Q41875965-4EA95BB2-8F4B-48FB-B55D-C2B1CA465EEFQ41998267-73134A03-1087-441D-955B-05A0BBAF7520Q42196156-F3545B7D-7457-4AD3-8E94-3CC6841CF486Q42961337-E9A4B5D1-FD07-49D8-9F2E-ECBB501EA955Q48356620-D2BB9502-929A-4881-BE96-B41AB597324DQ56986554-2DD745DE-4BF3-4B0C-ADB5-9359F86A1C18Q58556599-DC761E1E-704A-416F-A630-DD405B7EFDE9
P2860
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Adriamycin cardiotoxicity: a survey of 1273 patients.
@en
type
label
Adriamycin cardiotoxicity: a survey of 1273 patients.
@en
prefLabel
Adriamycin cardiotoxicity: a survey of 1273 patients.
@en
P2093
P1476
Adriamycin cardiotoxicity: a survey of 1273 patients.
@en
P2093
Bonadonna G
Castellani R
De Wasch G
Gallagher CG
P304
P577
1979-05-01T00:00:00Z